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DNA-responsive checkpoints prevent cell-
cycle progression following DNA damage or
replication inhibition. The mitotic activator
Cdc25 is suppressed by checkpoints through
inhibitory phosphorylation at Ser287 (Xenopus
numbering) and docking of 14-3-3. Ser287
phosphorylation is a major locus of G2/M
checkpoint control, although several check-
point-independent kinases can phosphorylate
this site.We reported previously thatmitotic en-
try requires 14-3-3 removal and Ser287 dephos-
phorylation. We show here that DNA-respon-
sive checkpoints also activate PP2A/B56d
phosphatase complexes to dephosphorylate
Cdc25 at a site distinct from Ser287 (T138),
the phosphorylation of which is required for
14-3-3 release. However, phosphorylation of
T138 is not sufficient for 14-3-3 release from
Cdc25. Our data suggest that creation of a
14-3-3 ‘‘sink,’’ consisting of phosphorylated
14-3-3 binding intermediate filament proteins,
including keratins, coupled with reduced
Cdc25-14-3-3 affinity, contribute to Cdc25 acti-
vation. These observations identify PP2A/B56d
as a central checkpoint effector and suggestCa mechanism for controlling 14-3-3 interactions
to promote mitosis.
INTRODUCTION
The master regulator of mitosis, Cdc2/Cyclin B, is in-
hibited by phosphorylation of Cdc2 on T14 and Y15, cat-
alyzed by the Myt1 andWee1 kinases. At the G2/M transi-
tion, these phosphorylations are reversed by the Cdc25
phosphatase, leading to Cdc2/Cyclin B activation and
mitosis (Lew and Kornbluth, 1996).
During interphase, Cdc25 is inhibited by Ser287 phos-
phorylation (Xenopus Cdc25; Ser216 in human Cdc25C),
and this inhibitory phosphorylation is maintained by DNA-
responsive checkpoints (Kumagai et al., 1998a; Peng
et al., 1997). Ser287 is targeted bymany kinases, including
Chk1, Chk2, cTAK-1, PKA, p38, and MAPKAP kinase-2,
suggesting that phosphorylation of this site may integrate
multiple signaling inputs (Duckworth et al., 2002; Furnari
et al., 1999; Manke et al., 2005; Peng et al., 1998).
Cdc25 Ser287 phosphorylation provides a docking site
for 14-3-3 protein (Dougherty and Morrison, 2004; Peng
et al., 1997). Although the role of this binding in regulating
Cdc25 catalytic activity has been controversial, 14-3-3
masks a nuclear localization sequence, preventing
Cdc25 nuclear translocation (Kumagai et al., 1998b;
Yang et al., 1999). A Cdc25 mutant that is neither phos-
phorylated at Ser287 nor binds 14-3-3 (Ser287A)ell 127, 759–773, November 17, 2006 ª2006 Elsevier Inc. 759
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promotes premature mitosis even in the presence of dam-
aged or incompletely replicated DNA (Kumagai et al.,
1998a; Peng et al., 1997). At mitosis, Cdc25 activation fol-
lows Ser287 dephosphorylation and 14-3-3 dissociation.
Although previous reports implied that 14-3-3 removal
resulted from Ser287 dephosphorylation, we recently re-
ported that 14-3-3 removal precedes and is required for
Ser287 dephosphorylation by protein phosphatase 1
(PP1) (Margolis et al., 2003). Thus, we hypothesized that
factors controlling 14-3-3 removal might be key targets
of DNA-responsive checkpoints.
Seeking to identify factors controlling 14-3-3 removal
from Cdc25, we found that phosphorylation of Cdc25 on
T138 by Cdk2 was required, explaining a previously re-
ported role for Cdk2 in regulating mitotic entry (Guadagno
and Newport, 1996; Margolis et al., 2003). These data did
not explain how 14-3-3 release might be checkpoint
regulated as Cdk2 activity was reportedly constitutive
throughout the cell cycle in the Xenopus egg extracts
used for our analyses (Guadagno and Newport, 1996;
Rempel et al., 1995). This suggested that regulation of
14-3-3 release must be exerted at some other level.
Although Cdc25 is negatively regulated by Ser287
phosphorylation, a role for phosphorylation in activating
Cdc25 has been proposed because PP2A can inhibit
Cdc25. At doses that inhibit PP2A selectively, okadaic
acid (OA) promotes Cdc25 activation and mitosis even
when DNA-responsive checkpoints are activated (Clarke
et al., 1993, Izumi et al., 1992; Kumagai et al., 1998a). Be-
cause PP2A has many substrates, the specific effects of
PP2A ablation on Cdc25 have not been studied. Thus, it
has not been clear how PP2A controls Cdc25 activation
and whether this regulation might be under checkpoint
control. In addition, the PP2A core enzyme, comprised
of the catalytic subunit (C) and a structural subunit (A),
can be directed to substrates by a number of different tar-
geting subunits (B), and the targeting subunit involved in
vertebrate Cdc25 regulation has not been identified.CWe report here that checkpoint-regulated release of 14-
3-3 from Cdc25 is controlled by PP2A bound to the B56d
targeting subunit. Binding of PP2A/B56d to Cdc25 main-
tains T138 dephosphorylation (and stable 14-3-3 binding)
during interphase. Importantly, Chk1 phosphorylation of
B56d enhances PP2A-mediated T138 dephosphorylation,
indicating that DNA-responsive checkpoints control
Cdc25 through PP2A rather than simply through Ser287
phosphorylation. Although T138 phosphorylation is criti-
cal for 14-3-3 release from Cdc25, it is not sufficient.
Rather, T138 phosphorylation reduces the affinity of 14-
3-3 for Cdc25, but efficient 14-3-3 removal involves the
creation of alternative docking sites for 14-3-3 on other
proteins at G2/M. We show that this 14-3-3 sink consists,
in Xenopus egg extracts, of phosphorylated keratin and
propose that other abundant mitotically phosphorylated
proteins may serve this role in other cell types. These
data show that PP2A is checkpoint controlled through tar-
geting subunit phosphorylation, suggesting that PP2A-
mediated T138 dephosphorylation is the most upstream
of the known regulatory events acting on Cdc25. In addi-
tion, our findings suggest a model in which the G2/M tran-
sition is driven in a concertedmanner both through control
of Cdc2 regulators and by phosphorylation of additional
cellular proteins that serve as docking sites for 14-3-3.
RESULTS
T138-Directed Phosphatase Activity Is Cell-Cycle
Regulated
The identification of Cdk2 as the T138-directed kinase
raised the issue of how this phosphorylation might be reg-
ulated, since Cdk2 kinase activity is constitutive during the
early Xenopus embryonic cell cycles (Guadagno and
Newport, 1996). T138 phosphorylation was absent in in-
terphase egg extracts (prepared with cycloheximide to
prevent Cyclin synthesis) and was induced by addition
of recombinant Cyclin B to drive mitosis (Figure 1A, left).Figure 1. T138 Dephosphorylation Is Cell-Cycle Regulated
(A) Wild-type (WT) and T138V GST-Cdc25 proteins were incubated in Xenopus egg interphase extract treated with Cyclin B1. Samples were retrieved
on glutathione-Sepharose at the indicated times, washed, and immunoblotted with anti-pT138 antibody (left). Asynchronous (A), interphase
(I, aphidicolin-treated), or mitotic (M, nocodazole-treated) HEK 293 cell lysates were immunoblotted with anti-pT138 antibody (right).
(B) Cycling extract samples taken at the indicated times were immunoblotted for pT138 and pY15 Cdc2. The arrow indicates nuclear envelope
breakdown.
(C)WT or T138VGST-Cdc25 was incubated in interphase extract +/OA treatment. Samples were retrieved on glutathione-Sepharose, washed, and
immunoblotted for pT138.
(D) N-terminal GST-Cdc25 was incubated in interphase extract +/ OA and +/ p21 and processed as in (C) for anti-pT138 blotting.
(E) GST-Cdc25 protein was incubated in buffer containing ATP +/ Cdk2/Cyclin E for 1 hr at 30C and processed as in (C).
(F) GST-Cdc25 was phosphorylated with Cdk2/Cyclin E, washed, and incubated in interphase extract (top) or in either interphase (I) or mitotic (M)
extract (bottom). Samples were processed as in (C) for anti-pT138 immunoblotting.
(G) WT or T138V GST-Cdc25, aa 108–200, was incubated with Cdk2/Cyclin E and [g-32P] ATP for 1 hr at 30C. Samples were resolved by SDS-PAGE
and visualized by autoradiography (top) or Coomassie blue stain (bottom).
(H) GST, WT, or T138V GST-Cdc25 108–200 proteins were phosphorylated as described in (G) and quantified by phosphorimager (left). Following
in vitro phosphorylation, proteins were incubated in I or M extracts and samples were taken at the indicated times, washed, and resolved by
SDS-PAGE. The % dephosphorylation was quantified by phosphorimager and represents the average of four experiments. Error bars represent
standard deviation (right).
(I) Endogenous Cdc25 was immunoprecipitated from interphase extract treated +/ OA. Samples were washed and immunoblotted with 14-3-3,
Cdc25, and pT138 antibodies. Arrows indicate IgG heavy chain or hypophosphorylated/hyperphosphorylated forms of Cdc25.ell 127, 759–773, November 17, 2006 ª2006 Elsevier Inc. 761
Similar cell-cycle variation in phosphorylation at this site
was seen for endogenous Cdc25C in human HEK 293
cells (T130 in Cdc25C) (Figure 1A, right). T138 phosphor-
ylation appeared before Cdc2 activation in cycling egg
extracts, as determined by Y15 dephosphorylation and
nuclear envelope breakdown (Figure 1B; data not shown).
These data raised the possibility that a T138-directed
phosphatase was cell-cycle controlled. Consistent with
this, addition of the phosphatase inhibitor, OA, to inter-
phase extracts induced T138 phosphorylation (Figure 1C).
Moreover, the Cdk2 inhibitor p21 diminished T138 phos-
phorylation in the OA-treated interphase extracts, con-
firming the role of Cdk2 in regulating 14-3-3 release from
Cdc25 (Figure 1D).
To demonstrate T138 dephosphorylation during inter-
phase, we phosphorylated GST-Cdc25 with Cdk2 in vitro
(Figure 1E), added this protein to interphase extracts, and
retrieved the protein on glutathione-Sepharose at various
times for anti-pT138 immunoblotting (Figure 1F, top). As
shown in Figure 1F (bottom), T138 was rapidly dephos-
phorylated in interphase, but not mitotic, extracts. Similar
results were obtainedwith a radiolabeled phosphopeptide
derived from Cdc25 (amino acids (aa) 108–200 containing
T138 as its only phosphorylation site) (Figures 1G and 1H).
These data show that T138-directed phosphatase activity
is cell-cycle regulated and suggest that 14-3-3 release
may be controlled by a T138-directed phosphatase. In-
deed, OA induced release of 14-3-3 from Cdc25 in inter-
phase extracts (Figure 1I).
Interphase Activation of T138-Directed PP2A Activity
OA induction of T138 phosphorylation suggested that PP1
or PP2A might regulate T138 phosphorylation. As shown
in Figure 2A, with concentrations of OA that inhibit
PP2A, but not PP1, the interphase extract could not pro-
mote T138 dephosphorylation of in vitro-phosphorylated
GST-Cdc25 (Margolis et al., 2003). In addition, the selec-
tive PP2A inhibitor, fostriecin, prevented T138 dephos-
phorylation at concentrations that prevent dephosphory-
lation of a known PP2A substrate, phosphorylase A,
arguing that PP2A dephosphorylates T138 in interphase
extracts (Figure 2B; Margolis et al., 2003).
PP2A activity is reportedly static during the cell cycle
(Clarke et al., 1993; Ruediger et al., 1991). Consistent
with this, PP2A dephosphorylated phosphorylase A simi-
larly in interphase and mitotic extracts, and no variation
in PP2A activity occurred in a cycling egg extract (Figures
2C and 2D). Thus, we hypothesized that cell-cycle oscilla-
tion in T138 dephosphorylation resulted from a specific
change in Cdc25-targeted PP2A activity.
B56d Mediates T138 Dephosphorylation
The PP2A core enzyme consists of a catalytic (C) subunit
and a regulatory/scaffolding (A) subunit. A regulatory/tar-
geting B subunit associates with the core, creating the ho-
loenzyme (PP2A A/B/C) (Mumby and Walter, 1993). We
wished to determine whether PP2A A/B/C could bind to
Cdc25 and, if so, which B subunit was present. As shown762 Cell 127, 759–773, November 17, 2006 ª2006 Elsevier Inc.in Figures 3A and 3B, Cdc25 coprecipitated with PP2A/C
in a 1:1 stoichiometry. In S. cerevisiae, two B subunits,
Cdc55 (B55 in vertebrates) and RTS1 (B56) have been
suggested to regulate Cdc25 (Minshull et al., 1996;
Wang and Burke, 1997; Yang et al., 2000; D. Lew, per-
sonal communication). Though we did not detect an inter-
action between Xenopus Cdc25 and B55, (Figure 3D, bot-
tom), B56 coprecipitated with Cdc25 from interphase
extracts and was retrieved from extracts with GST-
Cdc25 (Figures 3C and 3D, top). Human Cdc25C also co-
precipitated with HA-tagged B56 (d isoform) from trans-
fected HEK 293 cells (Figure 3E). Using a B56d-specific
antibody to immunoblot Xenopus extract and comparing
the electrophoretic mobility of the recognized band to
those in wild-type (WT) and B56d knockdown HEK 293
cell lysates, we identified the Xenopus Cdc25 bound
B56 as B56d (Figures S1 and 3D, top).
To determine if PP2A/B56d-Cdc25 binding was impor-
tant for T138 dephosphorylation, we created a series of
Cdc25 N-terminal fragments and assessed their PP2A/
B56d binding and susceptibility to T138 dephosphoryla-
tion. We found that aa 1–150 of Cdc25 bound weakly to
PP2A/B56d, while larger N-terminal fragments interacted
strongly (Figure 3F). Cdc25 peptides spanning aa 108–
200 (containing the PP2A docking site) or 108–150 (lack-
ing the docking site) were equally phosphorylated by
Cdk2, yet only the 108–200 peptide was dephosphory-
lated in interphase extract (Figure 3G, left and bottom
right). In addition, incubation of unphosphorylated 108–
150 peptide in interphase extracts resulted in net T138
phosphorylation, while incubation of the 108–200 peptide
did not (Figure 3G, top right), most likely because the
108–150 peptide could not be dephosphorylated.
To explore the role of B56d further, we performed mul-
tiple rounds of B56d immunodepletion from cytosolic in-
terphase egg extract. After three depletions, it was not
possible to precipitate additional B56d (Figure 3H). Fol-
lowing this depletion, pT138 accumulated on Cdc25 in
an interphase extract (Figure 3I). Moreover, removal of im-
munoprecipitable B56 resulted in a failure to dephosphor-
ylate T138 when we added Cdk2-phosphorylated Cdc25
to the extract, consistent with a critical role for B56 in
T138 dephosphorylation (Figure 3J). These data suggest
that association of B56d with Cdc25 is required for T138
dephosphorylation during interphase and that it is the
T138-directed phosphatase, rather than Cdk2, that is
cell-cycle regulated.
The DNA Replication Checkpoint Controls T138
Dephosphorylation
Given the importance of 14-3-3 in maintaining checkpoint
suppression of Cdc25 and the role of T138 phosphoryla-
tion in 14-3-3 release, we hypothesized that T138 dephos-
phorylation might be checkpoint regulated. To test this,
we examined Cdc25 dephosphorylation in Xenopus egg
extracts incubated with sperm chromatin and aphidicolin.
As shown in Figure 4A, we found that T138 dephosphory-
lation wasmarkedly accelerated by checkpoint activation.
Figure 2. Thr138 Is Dephosphorylated by PP2A
(A and B) GST-Cdc25 was phosphorylated with Cdk2/Cyclin E, washed, and incubated in interphase extract pretreated with increasing concentra-
tions of OA (A) or fostriecin (B). Samples were immunoblotted with anti-pT138 antibody. The percent of phosphorylase A dephosphorylated in the
presence of fostriecin is shown.
(C) [g-32P]-labeled phosphorylase A was incubated with increasing concentrations of interphase or mitotic extracts for 10 min in phosphatase buffer.
[g-32P] release from phosphorylase A was measured by scintillation counting.
(D) PP2A was immunoprecipitated from cycling extracts at the indicated times, washed, and incubated with Threonine phosphopeptide. The pmoles
of phosphate released were measured by colorimetric detection with Malachite Green Phosphate Detection Solution; results from three experiments
were averaged, and error bars represent standard deviation (top). Cell-cycle progression was monitored by Cdc2-Y15 immunoblotting (bottom).Since T138 dephosphorylation was cell-cycle con-
trolled, we speculated that alterations in PP2A/B56d-
Cdc25 binding might underlie this regulation. Using re-
combinant proteins, we found that both PP2A A/C and
B56d could interact directly and independently with
Cdc25; however, neither interaction varied with the cell
cycle (Figures 4B–4D). These data suggest that cellcycle-regulated T138 dephosphorylation was not the
result of altered binding of PP2A or B56d to Cdc25.
Chk1 Phosphorylates B56d
Cdc25 suppression by the replication checkpoint is con-
trolled by Chk1 and other checkpoint kinases. Therefore,
we speculated that maintenance of this suppression byCell 127, 759–773, November 17, 2006 ª2006 Elsevier Inc. 763
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T138 dephosphorylation might also be controlled by
checkpoint kinases. Accordingly, we examined in vitro
T138 dephosphorylation by PP2A A/C with B56d in the
presence and absence of Chk1. Interestingly, there was
little T138 dephosphorylation in the absence of Chk1,
and Chk1 markedly enhanced T138 dephosphorylation
(Figure 5A). Importantly, prior incubation of B56d with
Chk1 (with washes to remove Chk1), followed by incuba-
tion with Cdc25 and PP2A A/C, also enhanced T138 de-
phosphorylation (Figure 5A), suggesting that B56d might
be a Chk1 target. HumanB56d is a known phosphoprotein
(McCright et al., 1996), and B56 phosphorylation stimu-
lates the activity of PP2A toward specific substrates
in vitro (Usui et al., 1998). Moreover, B56d could serve
as an in vitro Chk1 substrate (Figure 5B). To identify the
site(s) of phosphorylation, we used phospho-antibodies
directed against four known phospho-sites on human
B56d (Usui et al., 1998; J.H.A. and A.C.N., unpublished
data). Although only two of these sites are conserved in
Xenopus B56d (Figure S2), a phospho-Ser37 antibody
recognized B56d in vitro phosphorylated by Chk1
(Figure 5C). In addition, the enhanced T138 dephosphor-
ylation observed upon preincubation of B56 with Chk1
was lost when S37A mutant B56 was used in the reaction
(data not shown). Moreover, Xenopus B56d added to in-
terphase egg extracts was phosphorylated at S37 and
dephosphorylated at mitosis, coincident with the appear-
ance of pT138 (Figures 5D and 5E). Importantly, S37 phos-
phorylation on endogenous Xenopus B56dwas enhanced
by replication checkpoint activation and blocked by caf-
feine (Figure 5F). Under checkpoint conditions, B56d
bound to Cdc25 was phosphorylated, and this phosphor-
ylation was blocked by UCN-01, which inhibits Chk1
(Figure 5G). Consistent with this, an 85% knockdown of
Chk1 protein by RNAi in HCT116 cells resulted in amarked
loss of phosphorylated B56d (Figure 5H). Collectively,
these data demonstrate that B56d serves as a Chk1Csubstrate, providing the first link between DNA-respon-
sive checkpoints and PP2A B targeting subunits.
B56d Phosphorylation Enhances PP2A Holoenzyme
Formation
To determine if B56d S37 phosphorylation was important
for interphase Cdc25 inhibition, we added B56d-S37A
protein to egg extracts. As shown in Figures 6A and 6B,
S37A, but not WT B56d, protein overrode a replication
checkpoint. Consistent with the idea that B56d-Cdc25 in-
teractions were not likely to be a key point of regulation,
B56d WT and S37A mutant bound equally well to Cdc25
(Figure 6C, top). In addition, in vitro phosphorylation of
B56dwith Chk1 did not alter its ability to bind recombinant
Cdc25 (Figure 6D). Rather, B56d phosphorylation by Chk1
enhanced its ability to bind the PP2A core, suggesting that
PP2A complex formation could be increased by check-
point function (Figure 6E). Chk1 did not similarly enhance
PP2A-B56d-S37A binding (Figure 6F). B56d-S37A protein
was also impaired in its ability to bind endogenous Xeno-
pusPP2A (Figure 6C). These data provided an explanation
for the ability of the S37A mutant B56d protein to impair
checkpoint suppression of Cdc25. Because S37 mutation
diminished recruitment of PP2A A/C without impairing
Cdc25 binding, we suspected that the S37Amutant acted
in a dominant-negative fashion in egg extracts, docking on
Cdc25 without interacting with the cobound PP2A core
enzyme. This impairment would allow inappropriate accu-
mulation of phospho-T138 even during interphase (or
checkpoint arrest), as seen in Figure 6G. We also found
that T138 dephosphorylation could be restored in extracts
depleted of B56d if recombinant WT B56d, pretreated with
Chk1, was added back to the depleted extracts. However,
similarly treated B56d-S37A could not restore T138 de-
phosphorylation (Figure 6H). T138 dephosphorylation
was somewhat slower in the depleted extracts supple-
mented with recombinant WT protein than in the mockFigure 3. The B56d Targeting Subunit Mediates Thr138 Dephosphorylation
(A) Cdc25 was immunoprecipitated from interphase extract with CNBr sepharose-coupled preimmune or anti-Cdc25 sera and immunoblotted with
anti-PP2A antibodies.
(B) Increasing amounts of endogenous Cdc25 were immunoprecipitated from interphase extracts, washed, and immunoblotted for PP2A and Cdc25
and compared to levels of Cdc25 and PP2A present in egg extracts.
(C) Cdc25 was immunoprecipitated as described in (A) and immunoblotted with anti-B56 and PP2A antibodies.
(D) GST or GST-Cdc25 linked to glutathione-Sepharose was incubated in interphase extract, collected, and immunoblotted for B56 (top) or B55
(bottom).
(E) HEK 293 cells were mock transfected (M) or transfected with HA-B56 isoforms (3, d, g1, g2, b, a) that were immunoprecipitated from cell lysates.
Immunoprecipitates were washed and immunoblotted with anti-Cdc25C and anti-HA antibodies (top). Total Cdc25C and HA-B56 proteins were blot-
ted for in cell lysates (bottom).
(F) C-terminally truncated GST-Cdc25 proteins were incubated in interphase extract, washed, and immunoblotted for B56.
(G) GST-Cdc25 aa 108–150 and 108–200, were prephosphorylated with Cdk2/Cyclin E and [g-32P] ATP (left). Fragments were incubated in interphase
extract, collected at the indicated times, and resolved by SDS-PAGE (bottom right). The % dephosphorylation was quantified by phosphorimager.
Nonphosphorylated fragments were incubated in interphase extract, collected at the indicated times, and resolved by SDS-PAGE for anti-pT138
immunoblotting (top right). Arrows indicate Cdc25 fragments.
(H) Cytosolic interphase extract was depleted of B56d with three sequential incubations with 10 mg of preimmune or anti-B56d antibodies coupled to
protein A-Sepharose. Beads were washed and immunoblotted with anti-B56d antibody. Arrow indicates B56d.
(I) Preimmune- and B56d-depleted extracts were incubated at room temperature with energy-regenerating mix. Samples were withdrawn at the in-
dicated times and immunoblotted for pT138 (arrow).
(J) GST-Cdc25 was phosphorylated in vitro with Cdk2/Cyclin E, washed, and incubated in preimmune- or B56d-depleted extracts. Samples were
withdrawn at the indicated times, washed, and immunoblotted for pT138.ell 127, 759–773, November 17, 2006 ª2006 Elsevier Inc. 765
Figure 4. Cell-Cycle Regulation of
Thr138 Dephosphorylation and 14-3-3
Release Depends on B56
(A) GST-Cdc25 prephosphorylated by Cdk2/
Cyclin Ewas incubated in untreated () or aphi-
dicolin-treated interphase extract for the indi-
cated times. Samples were collected, washed,
and immunoblotted for pT138.
(B) GST or GST-Cdc25 linked to glutathione-
Sepharose was incubated with recombinant
B56d +/ purified PP2A A/C in buffer. Samples
were washed and immunoblotted with the indi-
cated antibodies. Arrow indicates B56d.
(C) PP2A A/C was incubated in buffer with GST
or GST-Cdc25 linked to glutathione-Sephar-
ose. Samples were washed and immunoblot-
ted for PP2A.
(D) Cdc25 was immunoprecipitated from inter-
phase (I) or mitotic (M) extracts and immuno-
blotted for Cdc25, PP2A, or B56. Arrows indi-
cate IgG heavy chain versus B56 or Cdc25.
Mitotic Cdc25 (M) migrates more slowly than
interphase Cdc25 (I) due to hyperphosphoryla-
tion.depleted extract, probably reflecting the presence of
some inactive protein in the recombinant B56 preparation
(Figure 3J).
Consistent with a role for B56d-S37 phosphorylation in
regulating PP2A subunit interactions, GST-B56d bound
PP2A A/C poorly in Chk1-depleted extracts (Figure 6I).
Note that in Figures 6C and 6I, the amounts of recombi-
nant B56d used for the pull-downs were in excess of
endogenous Cdc25 (which would bridge interactions of
cobound proteins) in order to observe alterations in the
ability of free A/C subunits (which constitute50%of total
PP2A A/C in egg extracts (Lin et al., 1998) to bind B56 after
Chk1 phosphorylation. Thus, we propose that Chk1-medi-
ated suppression of Cdc25 acts at two distinct points:
Ser287 phosphorylation allows 14-3-3 docking, while en-
hancement of B56d-PP2A A/C association ensures that
the 14-3-3 will remain docked.
Thr138 Phosphorylation Is Required but Not
Sufficient for 14-3-3 Removal
Upon completion of DNA replication, PP2A-mediated
T138 dephosphorylation ceases, allowing 14-3-3 release.
However, when we treated recombinant 14-3-3-bound
Cdc25 with Cdk2/Cyclin E to phosphorylate T138, we
did not see any gross change in 14-3-3 binding (Figure 7A).
Nonetheless, Cdk2 phosphorylation of Cdc25 reduced
the apparent affinity of 14-3-3 for Cdc25 (Figure S3).
Moreover, Cdk2/CyclinE treatment rendered 14-3-3
more susceptible to dissociation from Cdc25 by high-
salt buffer (Figure 7B). These data suggest that T138766 Cell 127, 759–773, November 17, 2006 ª2006 Elsevier Inc.phosphorylation, while required to induce 14-3-3 release,
is not sufficient, but simply ‘‘loosens’’ 14-3-3 binding.
Consistent with this, isolation of 14-3-3-bound Cdc25
from interphase extracts followed by OA treatment al-
lowed phosphorylation of Cdc25 at T138 (presumably by
bound Cdk2, Figure 7D) without affecting 14-3-3 removal
(Figure 7C). These data suggest that a factor(s), present in
the full extract (Figure 1I), but not associated with the
precipitated complex, was required for efficient 14-3-3
release.
An Intermediate Filament Sink Contributes to 14-3-3
Removal from Cdc25
To identify the missing component(s) required for 14-3-3
release, we fractionated interphase egg extracts by ultra-
centrifugation at 200,000 3 g into cytosolic, light mem-
brane, heavy membrane, and pelletable (glycogen, ribo-
somes, assembled cytoskeletal proteins, and large
protein complexes) fractions. Addition of OA (or Cyclin
B) to the cytosol did not induce 14-3-3 release from
GST-Cdc25 (Figure 7E, data not shown). Adding each of
the other fractions back, we restored 14-3-3 removal
upon addition of the pelleted fraction to OA-treated cyto-
sol (Figure 7F). Interestingly, pretreatment of total extract
with OA prior to pelleting or usingmitotic, rather than inter-
phase, extract, as a source of pelletedmaterial, generated
14-3-3-releasing activity in the pure cytosol, relieving the
requirement for the pellet (Figure S4A). These data implied
that the pelleted fraction contained a component required
for 14-3-3 removal and that the active principle was
Figure 5. B56d Is Phosphorylated in a Checkpoint-Dependent Manner
(A) GST-Cdc25 linked to glutathione-Sepharose was incubated with Cdk2/Cyclin E in buffer containing ATP for 1 hr at 30C. The protein was washed
and incubated in fresh buffer containing ATP with PP2A A/C and B56d +/ recombinant Chk1 (left and middle column). GST-B56dwas preincubated
with Chk1 and ATP, washed extensively to remove Chk1, and then incubated in fresh buffer containing ATP, prephosphorylated GST-Cdc25, and
PP2A A/C (right column). Samples were retrieved at the indicated times and immunoblotted with pT138 antibody.
(B) GST, GST-Cdc25, or GST-B56dwas incubated with Chk1 in buffer containing [g-32P] ATP for 1 hr at 30C. Samples were resolved by SDS-PAGE
and analyzed by autoradiography.
(C) GST-B56d was incubated +/ Chk1 in buffer containing ATP. Samples were immunoblotted with anti-pS37 antibody.
(D) GST-B56d was incubated in interphase extract with Cyclin B. The arrow indicates mitotic entry. Samples were collected at the indicated times,
washed, and immunoblotted for pS37.
(E) GST-Cdc25 and GST-B56d were incubated in interphase and mitotic extracts and immunoblotted for pS37 and pT138.
(F) Interphase extracts supplemented with sperm chromatin were pretreated +/ 20 mg/ml aphidicolin (top) or with aphidicolin +/ 5 mM caffeine
(bottom). GST-B56d was incubated in extracts as indicated, washed, and immunoblotted for pS37. Arrow indicates pS37-B56d.
(G) GST or GST-Cdc25 was incubated in interphase extract pretreated with 20 mg/ml aphidicolin +/ 1 mMUCN-01, retrieved on glutathione-Sephar-
ose, and immunoblotted for pS37.
(H) Lysates from HCT116 cells or Chk1 knockdown HCT116 cells were immunoblotted for pS37, total B56, or Chk1. Arrow indicates B56d-pS37.Cell 127, 759–773, November 17, 2006 ª2006 Elsevier Inc. 767
Figure 6. B56d-S37A Overrides a Replication Checkpoint
(A) Cycling extracts were incubated with GST, B56d, or B56d-S37A +/ aphidicolin and sperm chromatin. Samples were taken at the indicated times
and immunoblotted for pY15-Cdc2 and anti-PSTAIRE antibody.
(B) Hoechst staining of DNA was monitored by fluorescence microscopy using extracts treated as in A.
(C) GST-B56d WT or GST-B56d-S37A was incubated in interphase extract, retrieved on glutathione-Sepharose, washed, and immunoblotted with
Cdc25 or PP2A antibodies.
(D) GST-B56d and His-Cdc25 proteins were incubated +/Chk1 in buffer with ATP. GST-B56dwas retrieved on glutathione-Sepharose, washed, and
analyzed by anti-His immunoblotting.
(E and F) WT or S37A GST-B56d was incubated with PP2A A/C +/ Chk1 in ATP-containing buffer at 30C. GST proteins were retrieved on gluta-
thione-Sepharose, washed, and immunoblotted with PP2A C and GST antibodies.768 Cell 127, 759–773, November 17, 2006 ª2006 Elsevier Inc.
pelletable during interphase but cytosolic in mitosis (or in
the presence of OA to promote pseudomitotic phosphory-
lations).
Interestingly, addition of 14-3-3 to extracts to double
the endogenous concentration (40 mg/ml) suppressed
both 14-3-3 release from Cdc25 and mitotic entry
(Figure S5). In considering this, we noted a publication
by Tzivion et al. (2000) in which treatment of COS-7 cells
with the phosphatase inhibitor calyculin A resulted in the
abundant association of phosphorylated vimentin with
14-3-3 at the expense of most other 14-3-3 protein
complexes. From this, they hypothesized that phospho-
vimentin (and perhaps other intermediate filament pro-
teins such as keratins) might, under specific physiological
conditions, provide high-affinity binding sites to sequester
14-3-3. From this, we speculated that addition of excess
14-3-3 to our extracts neutralized the 14-3-3 sink provided
by phosphorylated intermediate filament proteins, limiting
their ability to promote 14-3-3 removal from Cdc25,
thereby preventing mitotic entry.
Because 14-3-3 releasing activity was soluble in mitosis
(or OA-induced pseudomitosis) but pelletable in inter-
phase, we hypothesized that the activity might reside in
an intermediate filament protein that would be polymer-
ized in interphase (pelletable) and monomeric (soluble) in
mitosis. Therefore, relevant proteins pelleted during inter-
phase ought to be released into the cytosol during mitosis
to create a 14-3-3 sink. To evaluate this, we pelleted inter-
phase extracts and marked all precipitated proteins by
biotinylation. The biotinylated proteins were then added
to cytosolic interphase extracts treated with OA. The ex-
tracts were refractionated by centrifugation and the solu-
ble cytosolic proteins were bound to a GST-14-3-3 resin,
resolved by SDS-PAGE and probed with horseradish
peroxidase (HRP)-streptavidin (Figure S6). This resulted
in the capture of a small number of 14-3-3 binding part-
ners that had transitioned from a pelletable to a soluble
state (Figure 7G).
Given the hypothesis that prompted these experiments,
wewere struck by the presence of abundant proteins of 48
and 55 KD, the molecular weights of keratin 8/18, in the
profile of 14-3-3 binding partners. Because cells from ker-
atin knockout animals reportedly show defects in G2/M
progression (in some cell types), keratins were attractive
candidates for the 14-3-3 binding sink (Toivola et al.,
2001). Moreover, keratin 8/18 complexes are phosphory-
lated and bind 14-3-3 at mitosis (Ku et al., 1998; Ku et al.,
2002; Liao and Omary, 1996). Interestingly, OA treatment
of egg extracts or use of mitotic extract induced keratin 18
binding to 14-3-3, suggesting that phosphatase inhibitionis sufficient to allow phosphorylation of keratin at 14-3-3
binding sites to similar levels observed during mitosis
(Figure 7H). Given these data, we wished to determine
whether keratin depletion/add-back affected 14-3-3-
releasing activity. We found that 200,0003 g ultracentrifu-
gation of interphase extract removed >90% of the keratin,
while OA or Cyclin B preincubation caused an almost
complete release of keratin 18 into the cytoplasm (Fig-
ure 7I). Thus, we considered the cytosol to be a keratin-
depleted extract, which was deficient in 14-3-3-releasing
activity (Figure 7J, top). We then added back nanomolar
quantities of keratin 8/18 protein to the cytosolic extract
and measured 14-3-3 release in the presence or absence
of OA (Figure 7J, bottom). Interestingly, keratin addition
(140 nM) effectively restored 14-3-3 release. We also
found that addition of keratin back to ultraspun cytosol ac-
celerated entry into mitosis driven by added Cyclin B, as
measured by Cdc2 Y15 dephosphorylation and nuclear-
envelope breakdown (Figure 7K; data not shown). More-
over, in cycling egg extracts, keratin binding to 14-3-3
occurred in advance of Y15-Cdc2 dephosphorylation,
consistent with a role for keratin in Cdc25 activation (Fig-
ure 7L). Additionally, immunofluorescent staining of syn-
chronized HeLa cells demonstrated that keratin 18 phos-
phorylation at a previously characterized 14-3-3 binding
site occurred prior to mitotic entry and in the presence
of OA (Figures S4B and S4C) (Ku et al., 1998). In aggre-
gate, these data suggest that the reduction in affinity for
14-3-3 caused by PP2A/B56d regulation and consequent
accumulation of pT138 on Cdc25 could promote 14-3-3
removal due to the coincident mitotic phosphorylation of
intermediate filaments to create a 14-3-3 sink. Together,
these processes would allow efficient Cdc25 activation,
dephosphorylation of Cdc2, and mitotic entry.
DISCUSSION
Regulation of PP2A/B56d by DNA-Responsive
Checkpoints
DNA-responsive checkpoints control mitotic entry, in part,
by suppressing Cdc25 activation. While Ser287 phos-
phorylation by checkpoint kinases allows 14-3-3 docking
and Cdc25 inhibition, we show here that maintaining this
binding relies upon continued T138 dephosphorylation
by PP2A/B56d. Thus, PP2A/B56d represents a novel
checkpoint component. We have not yet determine if
this regulatory pathway controls human Cdc25 proteins,
though we note the conservation of T138 and 14-3-3 bind-
ing across isoforms (Figure S7).(G) Interphase extracts with Cyclin B were treated with aphidicolin in the presence of GST, B56d, or B56d-S37A. Samples were taken at the indicated
times and analyzed for pT138 phosphorylation.
(H) WT or B56d-S37A protein was preincubated with His-Chk1 in buffer containing ATP at 30C before being added to B56d-depleted cytosolic
extracts. GST-Cdc25 T138 dephosphorylation was monitored by removing samples at the indicated times, washing, and immunoblotting with
anti-pT138 antibody.
(I) GST-B56dwas incubated in interphase extracts immunodepleted of Chk1, retrieved, washed, and immunoblotted for pS37, B56d, and PP2A (left).
Mock or Chk1-depleted extracts were immunoblotted for Chk1 (right). Arrow indicates Chk1.Cell 127, 759–773, November 17, 2006 ª2006 Elsevier Inc. 769
Figure 7. A Keratin 14-3-3 Sink Promotes 14-3-3 Release from Cdc25
(A) Cdc25-14-3-3 complexes isolated from interphase extract were washed and incubated +/Cdk2/CyclinE at 30C for 1 hr. Samples were washed
with ELB + 300 mM NaCl and 0.1% Triton X-100 and immunoblotted with anti-14-3-3 sera.770 Cell 127, 759–773, November 17, 2006 ª2006 Elsevier Inc.
Because Ser287 is phosphorylated during an unper-
turbed interphase, it has been speculated that checkpoint
activation simply prolongs phosphorylation of this site un-
til DNA damage is repaired or replication is completed
(Sanchez et al., 1997; Zeng et al., 1998). Indeed, check-
point activation by DNA damage during interphase does
not result in a marked increase in total Ser287 phosphor-
ylation (Stanford and Ruderman, 2005). Once DNA is
repaired or replication is completed, loss of checkpoint ki-
nase activity is not sufficient to promote Cdc25 activation
because removal of 14-3-3 is required to allow Ser287
dephosphorylation. Thus, DNA-responsive checkpoints
must directly control 14-3-3 removal, which occurs inde-
pendently of and prior to Ser287 dephosphorylation. Our
data suggest that 14-3-3 removal is controlled through
checkpoint regulation of T138 dephosphorylation.
Unlike Ser287 phosphorylation, B56d phosphorylation
is dynamically controlled by checkpoints. This phosphor-
ylation enhances interaction of the PP2A A/C complex
with B56d, providing the first evidence of checkpoint mod-
ulation of PP2A holoenzyme composition. These data also
suggest that Cdc25 serves as a scaffold for B56d and
PP2A A/C as both of these proteins bind independently
to Cdc25 but are enhanced in their ability to interact with
each other following checkpoint activation.
Keratin Phosphorylation Promotes 14-3-3 Release
from Cdc25
Cdc25-T138 phosphorylation reduces 14-3-3 affinity suf-
ficiently that an increase in the availability of other 14-3-3
binding sites at mitosis promotes 14-3-3 dissociation. We
were surprised to identify keratin as a potential driver of
mitotic entry. These data are consistent with the prescient
prediction of Avruch and colleagues that phosphorylated
14-3-3 binding intermediate filament proteins might alter
signaling pathways through 14-3-3 sequestration (TzivionCet al., 2000). Interestingly, K8-null hepatocytes exhibit
mislocalized 14-3-3 protein as well as elevated numbers
of PCNA-positive S/G2-phase cells with doubled DNA
content, suggestive of a 14-3-3 mediated G2 arrest
(Toivola et al., 2001). Although these data may indicate that
the relevant sink in liver cells (as in egg extracts) is keratin,
we propose that other abundantly phosphorylated pro-
teins might perform this role in other cell types. A recent
report implicating K17-14-3-3 interactions in the regula-
tion of protein synthesis in epithelial cells also points to
a broader role of keratins in controlling fundamental cellu-
lar processes (Kim et al., 2006).
We have not yet identified the keratin-directed kinase,
though it is not likely to be Cdc2, because OA treatment
of interphase extracts, which lack Cyclin B, promotes ker-
atin-14-3-3 interactions. We observed 14-3-3 release
from Cdc25 upon OA treatment of complete extracts be-
cause this led to both keratin phosphorylation and T138
phosphorylation. Whether PP2A/B56d also dephosphory-
lates keratin is unknown. We also note that Cdc2/Cyclin B
might create novel 14-3-3 binding sites on keratin, thereby
contributing to positive feedback activation of Cdc25
by Cdc2.
A Model for Cdc25 Activation
We suggest that the following events control Cdc25 acti-
vation (Figure S8): during interphase, Ser287 is phosphor-
ylated and 14-3-3 is bound. When replication is ongoing,
checkpoint kinases phosphorylate S37 of B56d, maintain-
ing T138 dephosphorylation. Upon completion of replica-
tion, checkpoint kinases are turned off. We speculate,
based on previously published work, that PP2A can then
autodephosphorylate (Inoue et al., 1999; Tanabe et al.,
1996). Once B56d is dephosphorylated, pT138 accumu-
lates through constitutive Cdk2 action. Once sufficient
levels of phosphorylated sink proteins are achieved(B) The same experiment as in (A) was performed, but samples were washed with buffer containing increasing NaCl concentrations.
(C) Cdc25-14-3-3 complexeswere isolated as in (A) and incubated +/OAat 30C for 1 hr. Sampleswere collected, washed, and immunoblottedwith
anti-14-3-3 and anti-pT138 antibodies.
(D) GST or GST-Cdc25 linked to glutathione-Sepharose was incubated in interphase extract, washed, and processed for immunoblotting with anti-
Cdk2 antibody.
(E) GST-Cdc25-14-3-3 complexes were added to crude or cytosolic interphase egg extracts +/OA. Samples were washed and immunoblotted with
anti-14-3-3 sera.
(F) Extract was spun at 200,000 3 g. Four reactions were generated by either mixing all fractions together (reconstituted), cytosol alone, cytosol +
membrane, or cytosol + pellet. 14-3-3 bound GST-Cdc25 was incubated in each reaction + OA. Samples were collected at the indicated times,
washed with ELB + 300 mM NaCl and 0.1% Triton X-100, and immunoblotted for GST and 14-3-3.
(G) Crude interphase extract was spun at 200,0003 g. Pelleted proteins were biotinylated, added to cytosol, and incubated with dimethyl sulfoxide or
OA for 1 hr and repelleted at 200,000 3 g. GST-14-3-3 or GST was incubated in each extract for 1 hr at 4C. Samples were collected, washed, and
resolved by SDS-PAGE and probed with HRP-streptavidin.
(H) A similar experiment to that in (G) was done using nonbiotinylated pelleted protein, and samples were immunoblotted with anti-keratin sera (top).
The experiment was also performed using mitotic cytosol (bottom).
(I) Crude extract +/ OA or Cyclin B was spun at 200,000 3 g. Cytosolic extracts were treated with OA, and aliquots were taken for anti-keratin and
actin immunoblotting.
(J) Equal amounts of 14-3-3 bound GST-Cdc25 were incubated at room temperature for 1 hr in cytosolic extract +/OAwith 71 nM or 142 nM keratin
8/18. GST-Cdc25 was retrieved on glutathione-Sepharose, washed, and immunoblotted with anti-pT138 and anti-14-3-3.
(K) Keratin 8/18 or GST was added to cytosolic extract in the presence of light membrane and sperm chromatin. Nondegradable Cyclin was added to
extracts, and samples were taken at the indicated times and immunoblotted with anti-pY15 of Cdc2.
(L) GST-14-3-3 was incubated in cycling egg extract, retrieved at the indicated times on glutathione-Sepharose, washed, and immunoblotted with
anti-keratin. Entry into mitosis was monitored by anti-Y15-Cdc2 immunoblotting.ell 127, 759–773, November 17, 2006 ª2006 Elsevier Inc. 771
(e.g., phospho-keratin), 14-3-3 is released, allowing PP1
to dephosphorylate Ser287 and activate Cdc25. Cdc25
activates Cdc2/Cyclin B, which further activates Cdc25
(Margolis et al., 2006). Although Ser287 phosphorylation
of Cdc25must bemaintained to sustain checkpoint inhibi-
tion of Cdc25, our data demonstrate that a critical compo-
nent of checkpoint regulation lies with the PP2A-mediated
dephosphorylation of T138 and consequent release of
14-3-3.
EXPERIMENTAL PROCEDURES
Cloning and Protein Expression
N-terminal Cdc25 was cloned into pGEX-KG as described in Yang
et al. (1999). Xenopus B56d was cloned from a Xenopus cDNA library
using 50-CATGCCATGGGAATGCCTAATAAAAACAAGAAAGATAAA
GAACCTCC-30 and 50-CCGCTCGAGTCAAGTAAGGGCCCATCTGTT
TCC-30. GST-B56d-S37A was generated using the QuikChange Muta-
genesis Kit (Stratagene). HA-B56 proteins were cloned into pCEP4-
Lerner (McCright et al., 1996). Keratin 8/18 was purchased from
Prospec-Tany TechnoGene LTD. GST-14-3-33 was expressed as
described (Kumagai et al., 1998b).
Antibodies
Rabbit polyclonal anti-pT138 was raised against the peptide
LPHLLCSpTPSFKKAC. B56d antibody was raised and affinity purified
using the peptide QSQPPSSNKRPSNS (aa 49–62 of human B56d).
Phospho-B56 antibody was raised against KRPpSNSTP. Anti-14-3-33
(Santa Cruz), anti-PP2A (Upstate), anti-pan-B56 (Upstate), anti-phos-
pho-Cdc2 (Y15; Cell Signaling Technology), anti-Cdc25C (Abcam),
anti-cdk2 (Abcam), anti-keratin C11(Sigma), and anti-keratin-18 (Lab
Vision) antibodies were purchased.
Xenopus Extracts
Xenopus egg extracts and sperm chromatin were prepared as de-
scribed (Murray, 1991). Interphase extracts contained cycloheximide
to prevent Cyclin synthesis, while cycling extracts were prepared after
egg activation without cycloheximide. Nuclei stained with Hoechst
33258 were examined using a Zeiss Axioscop with a 40x Plan-Neofluar
air objective.
Cell Culture and Chk1 Knockdown
HeLa and HEK 293 cells were grown in Dulbecco’s Modified Eagle’s
Medium (Gibco) with 10% fetal bovine serum (FBS). HCT116 cells
were grown in McCoy’s 5A Medium Modified (Gibco) with 10% FBS.
Cells were transfected using PLUS reagent and Lipofectamine (Invitro-
gen). Where noted, cells were treatedwith 5 mg/ml aphidicolin or 40 ng/
ml nocodazole for 20 hr prior to harvest. Oligonucleotides targeting hu-
man Chk1 (50-CAGGAGAGAAGGCAATATC-30 and its compliment)
were cloned into pSUPER, and HCT116 cells were transfected with
Fugene 6 (Roche). Stable clones were selected with 500 mg/ml G418,
grown to confluency and examined for Chk1 expression by immuno-
blotting.
Protein Phosphorylation/Dephosphorylation
To generate phosphorylated GST-Cdc25, Cdk2/Cyclin E (Upstate) and
2 mg of GST-Cdc25 were incubated in kinase buffer (10 mM Tris-HCl
pH 7.5, 10 mM MgCl2, 1 mM DTT, 100 mM ATP) for 1 hr at 30
C.
Xenopus B56d was phosphorylated by incubating 2 mg GST-B56d or
GST-B56d-S37A with recombinant His-Chk1 in kinase buffer for 1 hr
at 30C.
Phosphorylated GST-Cdc25 bound to glutathione-Sepharose was
dephosphorylated in phosphatase buffer (50 mM Tris-HCl pH 7.5,
1 mM EDTA, 0.1% b-mercaptoethanol) supplemented with Xenopus
egg extract or purified PP2A A/C (Upstate) and recombinant B56d772 Cell 127, 759–773, November 17, 2006 ª2006 Elsevier Incand Chk1. PP2A activity was measured in cycling extracts using the
PP2A Immunoprecipitation Phosphatase Assay Kit (Upstate).
Coprecipitation and Immunodepletions
To analyze interactions between Cdc25 and PP2A or B56d, GST-
Cdc25 proteins were incubated in interphase extract for 1 hr at 4C, re-
trieved on glutathione-Sepharose, washed with egg lysis buffer (ELB:
250 mM sucrose, 2.5 mM MgCl2, 1 mM dithiothreitol [DTT], 50 mM
KCl, 10 mM Hepes pH 7.7) plus 150 mM NaCl and 0.05% Triton X-
100, and immunoblotted with anti-PP2A or anti-B56d. GST-Cdc25-
14-3-3 complexes were washed with ELB + 300 mM NaCl and 0.1%
Triton X-100.
To analyze purified protein interactions, N-terminal GST-Cdc25 or
GST was incubated with PP2A A/C (Upstate) in ELB + 0.1% bovine se-
rum albumin. Proteins were incubated at 4C for 1 hr and washed with
ELB + 150 mM NaCl and 0.05% Triton X-100 and analyzed by immu-
noblotting. GST-B56d or GST-B56d-S37A was incubated with PP2A
A/C and His-Chk1 in kinase buffer for 1 hr at 30C before washing
and immunoblotting.
Cytosolic interphase extract was depleted of Chk1 as reported
(Kumagai et al., 1998a) and was depleted of B56d by three sequential
30 min incubations with 10 mg purified polyclonal anti-B56d serum
coupled to protein A-Sepharose.
To analyze human protein interactions, cell lysates were prepared as
described (Eide et al., 2002). HA-tagged proteins were immunoprecip-
itated from 300 mg total protein with anti-HA antibody (Santa Cruz, CA)
and collected with 20 ml protein A agarose (Invitrogen). Beads were
washed with lysis buffer (150 mM NaCl, 30 mM HEPES pH 7.4, 0.1%
Tween 20) and immunoblotted. Proteins were biotinylated using the
ECL Biotinylation Module (Amersham) and quenched with the Avidin/
Biotin Blocking Kit (Zymed).
Supplemental Data
Supplemental Data include eight figures and can be found with this
article online at http://www.cell.com/cgi/content/full/127/4/759/DC1/.
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